Exact Sciences (EXAS) Fundamental Analysis: Revenue, Earnings & Valuation

5.37 / 10

Netural

Fundamental analysis rates Exact Sciences as neutral (5.4/10). Profit‑MV and Cash‑MV are strong, while Asset‑MV and Revenue‑MV lag peers. Gross profit margin shows weakness, dragging the score. Overall, the fundamentals are fair with modest profitability and cash strength.

Analysis Checks(9/10)

Revenue-MV

Value-0.67

Score3/3

Weight31.45%

1M Return9.51%

Inventory turnover ratio

Value5.99

Score2/3

Weight-1.17%

1M Return-0.56%

Gross profit margin (%)

Value69.69

Score0/3

Weight-9.21%

1M Return-5.42%

Profit-MV

Value0.68

Score2/3

Weight18.06%

1M Return6.36%

Income tax / Total profit (%)

Value-1.99

Score2/3

Weight2.27%

1M Return0.98%

Current assets turnover ratio

Value2.08

Score2/3

Weight4.15%

1M Return1.91%

Fixed assets turnover ratio

Value3.96

Score2/3

Weight0.02%

1M Return0.01%

Cost of sales ratio (%)

Value30.31

Score2/3

Weight-7.40%

1M Return-3.62%

Asset-MV

Value-0.55

Score2/3

Weight44.13%

1M Return13.10%

Cash-MV

Value-0.96

Score2/3

Weight17.70%

1M Return6.19%

Is EXAS fundamentally strong?

EXAS scores 5.37/10 on fundamentals and holds a Fair valuation at present. Backed by its -8.66% ROE, -6.40% net margin, -96.30 P/E ratio, 8.34 P/B ratio, and 80.32% earnings growth, these metrics solidify its Netural investment rating.

EXAS(Delisted)

Analysis Checks(9/10)